Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS)
600538.SS Stock Price Chart
Explore Beihai Gofar Chuanshan Biological Co., Ltd. interactive price chart. Choose custom timeframes to analyze 600538.SS price movements and trends.
600538.SS Company Profile
Discover essential business fundamentals and corporate details for Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) to support your stock research and investment decisions.
Sector
Basic Materials
Industry
Agricultural Inputs
IPO Date
14 Jan 2003
Employees
453.00
Website
https://www.gofar.com.cnCEO
Bin Pan Li
Description
Beihai Gofar Chuanshan Biological Co., Ltd. engages in the production and distribution of pharmaceutical products in China. The company offers various medicines and medical devices; and produces and sells pearl eyesight eye drops, gastrointestinal granules, pearl powder, and other proprietary Chinese medicines. It also provides molecular medical imaging and tumor radiotherapy centers, as well as tumor telemedicine technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in May 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was founded in 1993 is based in Beihai, China.
600538.SS Financial Timeline
Browse a chronological timeline of Beihai Gofar Chuanshan Biological Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 16 May 2025
EPS came in at -¥0.14 , while revenue for the quarter reached ¥76.99M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.01 , while revenue for the quarter reached ¥78.61M .
Earnings released on 30 Sept 2024
EPS came in at -¥0.01 , while revenue for the quarter reached ¥86.74M .
Earnings released on 30 Jun 2024
EPS came in at -¥0.01 , while revenue for the quarter reached ¥88.29M .
Earnings released on 17 May 2024
EPS came in at -¥0.13 , while revenue for the quarter reached ¥85.89M .
Earnings released on 31 Mar 2024
EPS came in at -¥0.02 , while revenue for the quarter reached ¥87.57M .
Earnings released on 30 Sept 2023
EPS came in at -¥0.01 , while revenue for the quarter reached ¥89.01M .
Earnings released on 30 Jun 2023
EPS came in at -¥0.01 , while revenue for the quarter reached ¥92.67M .
Earnings released on 31 Mar 2023
EPS came in at -¥0.00 , while revenue for the quarter reached ¥101.58M .
Earnings released on 31 Dec 2022
EPS came in at ¥0.00 , while revenue for the quarter reached ¥121.26M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.03 , while revenue for the quarter reached ¥119.17M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.00 , while revenue for the quarter reached ¥98.42M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.01 , while revenue for the quarter reached ¥120.84M .
Earnings released on 31 Dec 2021
EPS came in at ¥0.00 , while revenue for the quarter reached ¥120.09M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.01 , while revenue for the quarter reached ¥114.53M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.00 , while revenue for the quarter reached ¥96.09M .
Earnings released on 27 Apr 2021
EPS came in at ¥0.02 , while revenue for the quarter reached ¥86.36M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.01 , while revenue for the quarter reached ¥94.01M .
Earnings released on 30 Sept 2020
EPS came in at -¥0.00 , while revenue for the quarter reached ¥63.89M .
600538.SS Stock Performance
Access detailed 600538.SS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.